Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2

SARS-CoV-2 is the viral agent responsible for the pandemic that in the first months of 2020 caused about 400,000 deaths. Among compounds proposed to fight the SARS-CoV-2-related disease (COVID-19), tyrosine kinase inhibitors (TKIs), already effective in Philadelphia-positive acute lymphoblastic leuk...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Galimberti, Sara, Petrini, Mario, Baratè, Claudia, Ricci, Federica, Balducci, Serena, Grassi, Susanna, Guerrini, Francesca, Ciabatti, Elena, Mechelli, Sandra, Di Paolo, Antonello, Baldini, Chiara, Baglietto, Laura, Macera, Lisa, Spezia, Pietro Giorgio, Maggi, Fabrizio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493657/
https://ncbi.nlm.nih.gov/pubmed/33014780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01428
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados